23.09.2019
Cerenion named #1 “Rising Star” by the Nordic Life Science Magazine
The latest issue of the Nordic Life Science Magazine (03/2019) has named five nordic companies, one from each nordic country, to its list of up-and-coming life science startups. Cerenion Oy holds the pole position among the companies chosen at number 1.
"It is a deep honor for us to be recognized in this way, and to represent Finland in this stellar group of nordic life science startups", says Dr. Timo Koskela, CEO of Cerenion.
The other companies are Coripharma from Iceland (#2), PCI Biotech from Norway (#3), Particle3D from Denmark (#4) and Cellink from Sweden (#5).
To read the 4-page article on us, and the stories on the other four companies, head on over to . To stay tuned to our future news follow us on .
the magazine
https://nordiclifescience.org/
LinkedIn
https://www.linkedin.com/company/cerenion/
Highlights
This website and all of the content therein is for reference purposes only and is not intended to substitute for advice from a licensed healthcare professional. Not available in the United States. Cerenion™, Cerenion C-Trend™, C-Trend™, "The next-generation brain monitoring company"™ and "The pulse of the brain"™ are registered trademarks and/or trademarks of Cerenion Oy. Cerenion C-Trend™ is intended for use by qualified medical practitioners who will exercise professional judgment in its use. Cerenion technology is protected by Intellectual Property Rights. Patents pending worldwide. All rights reserved. © Cerenion Oy 2020.